Recent progress and structural analyses of domain‐selective BET inhibitors
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent progress and structural analyses of domain‐selective BET inhibitors
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume 43, Issue 4, Pages 972-1018
Publisher
Wiley
Online
2023-03-27
DOI
10.1002/med.21942
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Structure-based Design Approach for Generating High Affinity BRD4 D1-Selective Chemical Probes
- (2022) Huarui Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site
- (2022) Zhiqing Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- CRCM5484: A BET-BDII Selective Compound with Differential Anti-leukemic Drug Modulation
- (2022) Kendall Carrasco et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Discovery and Optimization of Furo[3,2-c]pyridin-4(5H)-one Derivatives as Potent and Second Bromodomain (BD2)-Selective Bromo and Extra Terminal Domain (BET) Inhibitors
- (2022) Junhua Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections
- (2022) Ram K. Modukuri et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader
- (2022) Anand Divakaran et al. ACS Medicinal Chemistry Letters
- Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials
- (2021) Yanli Sun et al. Frontiers in Pharmacology
- Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development
- (2021) Pan Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Template-Hopping Approach Leads to Potent, Selective, and Highly Soluble Bromo and Extraterminal Domain (BET) Second Bromodomain (BD2) Inhibitors
- (2021) Helen E. Aylott et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and characterization of bromodomain 2–specific inhibitors of BRDT
- (2021) Zhifeng Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Resistance to BET inhibitors in lung adenocarcinoma is mediated by casein kinase phosphorylation of BRD4
- (2021) Jack Calder et al. Oncogenesis
- Identification of a Series of N-Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal Domain (BET) Proteins
- (2021) Lee A. Harrison et al. JOURNAL OF MEDICINAL CHEMISTRY
- Optimization of a Series of 2,3-Dihydrobenzofurans as Highly Potent, Second Bromodomain (BD2)-Selective, Bromo and Extra-Terminal Domain (BET) Inhibitors
- (2021) Simon C. C. Lucas et al. JOURNAL OF MEDICINAL CHEMISTRY
- 4-Methyl-1,2,3-Triazoles as N-Acetyl-Lysine Mimics Afford Potent BET Bromodomain Inhibitors with Improved Selectivity
- (2021) Huarui Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer
- (2020) Emily J. Faivre et al. NATURE
- Covalent-Fragment Screening of BRD4 Identifies a Ligandable Site Orthogonal to the Acetyl-Lysine Binding Sites
- (2020) Michael D. Olp et al. ACS Chemical Biology
- Discovery of N-Ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide (ABBV-744), a BET Bromodomain Inhibitor with Selectivity for the Second Bromodomain
- (2020) George S. Sheppard et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation
- (2020) Zhiqing Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
- (2020) Yuanjun Lu et al. Molecular Cancer
- Selective targeting of BD1 and BD2 of the BET proteins in cancer and immuno-inflammation
- (2020) Omer Gilan et al. SCIENCE
- The Design and Synthesis of a Highly Selective and In Vivo Capable Inhibitor of the Second Bromodomain (BD2) of the Bromodomain and Extra Terminal Domain (BET) Family of Proteins
- (2020) Alex Preston et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Optimisation of a Novel, Weak Bromo and Extra Terminal Domain (BET) Bromodomain Fragment Ligand to a Potent and Selective Second Bromodomain (BD2) Inhibitor
- (2020) Jonathan Thomas Seal et al. JOURNAL OF MEDICINAL CHEMISTRY
- GSK789: A Selective Inhibitor of the First Bromodomains (BD1) of the Bromo and Extra Terminal Domain (BET) Proteins
- (2020) Robert J. Watson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Design of a Bromodomain and Extraterminal Domain (BET) Inhibitor Selective for the N-Terminal Bromodomains That Retains an Anti-inflammatory and Antiproliferative Phenotype
- (2020) Christopher R. Wellaway et al. JOURNAL OF MEDICINAL CHEMISTRY
- GSK973 Is an Inhibitor of the Second Bromodomains (BD2s) of the Bromodomain and Extra-Terminal (BET) Family
- (2020) Alex Preston et al. ACS Medicinal Chemistry Letters
- Selective N‐terminal BRD4 bromodomain inhibitors by targeting non‐conserved residues and structured water displacement
- (2020) William Charles Krause Pomerantz et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Endothelial p300 Promotes Portal Hypertension and Hepatic Fibrosis Through C‐C Motif Chemokine Ligand 2–Mediated Angiocrine Signaling
- (2020) Jinhang Gao et al. HEPATOLOGY
- Binding pocket-based design, synthesis and biological evaluation of novel selective BRD4-BD1 inhibitors
- (2019) Junlong Ma et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma
- (2019) Pratiti Bandopadhayay et al. Nature Communications
- Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins
- (2019) Deheng Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Exploiting a water network to achieve enthalpy-driven, bromodomain-selective BET inhibitors
- (2018) William R. Shadrick et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain
- (2018) Robert P. Law et al. JOURNAL OF MEDICINAL CHEMISTRY
- The dTAG system for immediate and target-specific protein degradation
- (2018) Behnam Nabet et al. Nature Chemical Biology
- Optimization of a “bump-and-hole” approach to allele-selective BET bromodomain inhibition
- (2018) A. C. Runcie et al. Chemical Science
- Resistance to BET Inhibitor Leads to Alternative Therapeutic Vulnerabilities in Castration-Resistant Prostate Cancer
- (2018) Aishwarya Pawar et al. Cell Reports
- Design and Characterization of Novel Covalent Bromodomain and Extra-Terminal Domain (BET) Inhibitors Targeting a Methionine
- (2018) Olesya A. Kharenko et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular Basis for the N-Terminal Bromodomain and Extra Terminal (BET) Family Selectivity of a Dual Kinase-Bromodomain Inhibitor
- (2018) Anand Divakaran et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Co-operation of RUNX1 with LDB1, CDK9 and BRD4 Drives Transcription Factor Complex Relocation During Haematopoietic Specification
- (2018) Jane Gilmour et al. Scientific Reports
- Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains
- (2018) Jean-Philippe Lambert et al. MOLECULAR CELL
- BET N-terminal bromodomain inhibition selectively blocks Th17 cell differentiation and ameliorates colitis in mice
- (2017) Kalung Cheung et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Click chemistry enables preclinical evaluation of targeted epigenetic therapies
- (2017) Dean S. Tyler et al. SCIENCE
- Brd4 binds to active enhancers to control cell identity gene induction in adipogenesis and myogenesis
- (2017) Ji-Eun Lee et al. Nature Communications
- Epigenetic dysregulation of interleukin 8 (CXCL8) hypersecretion in cystic fibrosis airway epithelial cells
- (2016) Anna Poghosyan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Exploring Selective Inhibition of the First Bromodomain of the Human Bromodomain and Extra-terminal Domain (BET) Proteins
- (2016) Brigitt Raux et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification and Development of 2,3-Dihydropyrrolo[1,2-a]quinazolin-5(1H)-one Inhibitors Targeting Bromodomains within the Switch/Sucrose Nonfermenting Complex
- (2016) Charlotte L. Sutherell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Identification of a Chemical Probe for Family VIII Bromodomains through Optimization of a Fragment Hit
- (2016) Brian S. Gerstenberger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Twenty Crystal Structures of Bromodomain and PHD Finger Containing Protein 1 (BRPF1)/Ligand Complexes Reveal Conserved Binding Motifs and Rare Interactions
- (2016) Jian Zhu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis
- (2016) Vassilios Myrianthopoulos et al. JOURNAL OF MEDICINAL CHEMISTRY
- A poised fragment library enables rapid synthetic expansion yielding the first reported inhibitors of PHIP(2), an atypical bromodomain
- (2016) Oakley B. Cox et al. Chemical Science
- A bromodomain–DNA interaction facilitates acetylation-dependent bivalent nucleosome recognition by the BET protein BRDT
- (2016) Thomas C. R. Miller et al. Nature Communications
- BRD4 Phosphorylation Regulates HPV E2-Mediated Viral Transcription, Origin Replication, and Cellular MMP-9 Expression
- (2016) Shwu-Yuan Wu et al. Cell Reports
- Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules
- (2015) Andrew K. Urick et al. ACS Chemical Biology
- Functions of BET proteins in erythroid gene expression
- (2015) Aaron J. Stonestrom et al. BLOOD
- New Synthetic Routes to Triazolo-benzodiazepine Analogues: Expanding the Scope of the Bump-and-Hole Approach for Selective Bromo and Extra-Terminal (BET) Bromodomain Inhibition
- (2015) Matthias G. J. Baud et al. JOURNAL OF MEDICINAL CHEMISTRY
- BET inhibitor resistance emerges from leukaemia stem cells
- (2015) Chun Yew Fong et al. NATURE
- A Subset of Human Bromodomains Recognizes Butyryllysine and Crotonyllysine Histone Peptide Modifications
- (2015) E. Megan Flynn et al. STRUCTURE
- Selective targeting of the BRG/PB1 bromodomains impairs embryonic and trophoblast stem cell maintenance
- (2015) O. Fedorov et al. Science Advances
- Disrupting the Interaction of BRD4 with Diacetylated Twist Suppresses Tumorigenesis in Basal-like Breast Cancer
- (2014) Jian Shi et al. CANCER CELL
- Selective Chemical Modulation of Gene Transcription Favors Oligodendrocyte Lineage Progression
- (2014) Mar Gacias et al. CHEMISTRY & BIOLOGY
- Fragment-Based Screening of the Bromodomain of ATAD2
- (2014) Mary J. Harner et al. JOURNAL OF MEDICINAL CHEMISTRY
- NF-κB Directs Dynamic Super Enhancer Formation in Inflammation and Atherogenesis
- (2014) Jonathan D. Brown et al. MOLECULAR CELL
- The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
- (2014) Junwei Shi et al. MOLECULAR CELL
- A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes
- (2014) M. G. J. Baud et al. SCIENCE
- Assessing cellular efficacy of bromodomain inhibitors using fluorescence recovery after photobleaching
- (2014) Martin Philpott et al. Epigenetics & Chromatin
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- BET Bromodomains Mediate Transcriptional Pause Release in Heart Failure
- (2013) Priti Anand et al. CELL
- BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
- (2013) A. C. Belkina et al. JOURNAL OF IMMUNOLOGY
- Discovery of Epigenetic Regulator I-BET762: Lead Optimization to Afford a Clinical Candidate Inhibitor of the BET Bromodomains
- (2013) Olivier Mirguet et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Guided Design of Potent Diazobenzene Inhibitors for the BET Bromodomains
- (2013) Guangtao Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting
- (2013) Shwu-Yuan Wu et al. MOLECULAR CELL
- The bromodomain protein Brd4 insulates chromatin from DNA damage signalling
- (2013) Scott R. Floyd et al. NATURE
- Genome-wide localization of small molecules
- (2013) Lars Anders et al. NATURE BIOTECHNOLOGY
- Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA
- (2013) Z Zou et al. ONCOGENE
- RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain
- (2013) S. Picaud et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Small-Molecule Inhibition of BRDT for Male Contraception
- (2012) Martin M. Matzuk et al. CELL
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- The bromodomain interaction module
- (2012) Panagis Filippakopoulos et al. FEBS LETTERS
- Bromodomain-containing Protein 4 (BRD4) Regulates RNA Polymerase II Serine 2 Phosphorylation in Human CD4+ T Cells
- (2012) Weishi Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Place your BETs: the therapeutic potential of bromodomains
- (2012) R.K. Prinjha et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- The first bromodomain of the testis-specific double bromodomain protein Brdt is required for chromocenter organization that is modulated by genetic background
- (2011) Binyamin D. Berkovits et al. DEVELOPMENTAL BIOLOGY
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Targeting MYC dependence in cancer by inhibiting BET bromodomains
- (2011) J. A. Mertz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RVX-208
- (2010) Dana Bailey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Brd4 Coactivates Transcriptional Activation of NF- B via Specific Binding to Acetylated RelA
- (2008) B. Huang et al. MOLECULAR AND CELLULAR BIOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now